Stockscreener 앱 받기
0.2007
5.42%
-0.0115
시간 외 거래:
.20
-0.0007
-0.35%
Liminatus Pharma Inc 주식(LIMN)의 최신 뉴스
Liminatus eyes clinic with CD47-blockade antibody IBA-101 - BioWorld MedTech
Liminatus Pharma to initiate Phase 1 clinical trial for IBA101 antibody - TipRanks
Liminatus Pharma’s IBA101 May Represent the CD47 Innovation Addressing Anemia and Thrombocytopenia in Advanced Immuno-Oncology - Bitget
Liminatus Pharma announces planned phase 1 clinical trial of IBA101, a next-generation CD47 blocking antibody - marketscreener.com
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody - The Manila Times
Liminatus Pharma Announces Planned Phase 1 Clinical Trial Of Iba101, A Next-Generation Cd47 Blocking Antibody - TradingView
New 'don't-eat-me' cancer antibody to be tested in Liminatus lung trial - Stock Titan
LIMN Stock Price, Quote & Chart | LIMINATUS PHARMA INC-CL A (NASDAQ:LIMN) - ChartMill
Aug Movers: Is Liminatus Pharma Inc stock a top performer YTD2026 Trends & Smart Money Movement Tracker - baoquankhu1.vn
Reviewing Athira Pharma (NASDAQ:LONA) and Liminatus Pharma (NASDAQ:LIMN) - Defense World
Insider Trends: Is Liminatus Pharma Inc Equity Warrant subject to activist investor interestWeekly Trade Recap & Reliable Volume Spike Alerts - baoquankhu1.vn
Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance - MSN
Aug Mood: Is Liminatus Pharma Inc a strong growth stock2026 Breakouts & Fast Moving Stock Trade Plans - baoquankhu1.vn
How Liminatus Pharma Inc. stock responds to policy changesQuarterly Earnings Report & Expert Curated Trade Setup Alerts - Naître et grandir
Winners Losers: Is Liminatus Pharma Inc Equity Warrant subject to activist investor interestJuly 2025 Drop Watch & Weekly Momentum Picks - baoquankhu1.vn
Liminatus Pharma Lowers Quorum Requirement in Bylaw Amendment - TipRanks
Aug Update: Is Liminatus Pharma Inc stock a smart retirement pickJuly 2025 Retail & Reliable Entry Point Trade Alerts - baoquankhu1.vn
LIMN Earnings History & Surprises | EPS & Revenue Results | LIMINATUS PHARMA INC-CL A (NASDAQ:LIMN) - ChartMill
LIMN Should I Buy - Intellectia AI
Basic earnings per share (basic EPS) of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Liminatus Pharma Inc. (NASDAQ:LIMN) Short Interest Up 4,357.6% in February - Defense World
LIMN PE Ratio & Valuation, Is LIMN Overvalued - Intellectia AI
Free float of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Critical Analysis: Liminatus Pharma (NASDAQ:LIMN) and Athira Pharma (NASDAQ:LONA) - Defense World
Net income of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Liminatus Pharma, Inc. Dividends – NASDAQ:LIMNW - TradingView
Liminatus Pharma, Inc. Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation - The Ames Tribune
Aug EndMonth: What are Liminatus Pharma Incs recent SEC filings showingQuarterly Profit Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Earnings Risk: What are Liminatus Pharma Incs recent SEC filings showing2025 Top Gainers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Can Liminatus Pharma Inc. Equity Warrant stock deliver strong Q4 earnings2025 Historical Comparison & AI Forecast Swing Trade Picks - mfd.ru
Trend Recap: What is QSIAWs valuation compared to sectorProfit Target & High Conviction Investment Ideas - baoquankhu1.vn
Liminatus Pharma Completes $4 Million Public Equity Offering - The Globe and Mail
Liminatus Pharma Prices $0.29 Equity Offering, Nets $3.46 Million Under Securities Purchase Pact - TradingView
Aug Highlights: Can Liminatus Pharma Inc Equity Warrant be recession proofJuly 2025 Short Interest & Verified Stock Trade Ideas - baoquankhu1.vn
Liminatus Pharma prices $4 million public offering at $0.29 per share - Investing.com India
Liminatus Pharma prices 13.8M shares at 29c in public offering - TipRanks
Gold Down 3%; Medtronic Earnings Top Views - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering - Bitget
BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - The Manila Times
Bond Watch: What dividend growth rate does Sun Communities Inc offerWeekly Market Report & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
History Review: Is MasterBrand Inc benefiting from interest rate changesPortfolio Growth Summary & Accurate Intraday Trade Tips - baoquankhu1.vn
Is Liminatus Pharma Inc. Equity Warrant subject to activist investor interestTrade Volume Report & Long-Term Investment Growth Plans - mfd.ru
Published on: 2026-02-15 22:28:13 - mfd.ru
Can Liminatus Pharma Inc. Equity Warrant be recession proofTake Profit & Safe Capital Investment Plans - mfd.ru
Why Liminatus Pharma Inc. Equity Warrant stock is recommended by analysts2025 Market Overview & AI Driven Price Predictions - mfd.ru
Bond Watch: Can Xtant Medical Holdings Inc. (XMS) stock withstand sector downturnsJuly 2025 Volume & Long Hold Capital Preservation Tips - mfd.ru
Is WisdomTree Europe Hedged Equity Fund stock among top earnings playsJuly 2025 Price Swings & Comprehensive Market Scan Reports - mfd.ru
Can Liminatus Pharma Inc. Equity Warrant stock maintain growth trajectoryJuly 2025 Update & High Accuracy Trade Signal Alerts - mfd.ru
LIMN Technical Analysis & Stock Price Forecast - Intellectia AI
How do insiders feel about Liminatus Pharma Inc.Quarterly Profit Review & AI Enhanced Trading Signals - mfd.ru
Why Liminatus Pharma Inc. Equity Warrant stock attracts global investorsJuly 2025 Drop Watch & Real-Time Buy Signal Alerts - mfd.ru
Can Liminatus Pharma Inc. Equity Warrant outperform under higher oil prices2025 Retail Activity & Daily Market Momentum Tracking - mfd.ru
LIMN Liminatus Pharma (NASDAQ) pre-market +15% Feb 12 2026: earnings preview - Meyka
What are Liminatus Pharma Inc.’s recent SEC filings showingWeekly Trend Report & Free Weekly Chart Analysis and Trade Guides - mfd.ru
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Can Liminatus Pharma Inc. Equity Warrant reach resistance levels soon2025 Biggest Moves & Daily Profit Maximizing Tips - mfd.ru
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Highs Report: Is Liminatus Pharma Inc Equity Warrant stock showing strong momentumJuly 2025 Fed Impact & Community Trade Idea Sharing Platform - baoquankhu1.vn
LIMN down 26.83% intraday: Liminatus Pharma (NASDAQ) 09 Feb 2026 earnings ahead - Meyka
Liminatus Pharma Settles Litigation Through Equity Issuance - TipRanks
Liminatus Pharma enters settlement agreement with Clear Street LLC - marketscreener.com
Liminatus Pharma Enters Settlement Agreement With Clear Street LLC - TradingView
1.20%
0.06%
자본화:
|
볼륨(24시간):